Avlar
Avlar BioVentures is a venture capital firm that offers seed- and early-stage investments.
Business Model:
Revenue: $14.4M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Avlar Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund II (£43m) and the First Cambridge Gateway Fund (£35m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought by public companies, two have been sold for cash and two listed on the public markets. Prior to the formation of Avlar Messrs Roach and Goodman co-founded or seed financed nine life science companies. Seven of these were listed on recognized Stock Exchanges producing highly profitable realizations. These included Acambis, Chiroscience, Core, Salix and Oxford Biomedica.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2000 | Intercytex Group | Venture Round | 1.4M |
| 10/2009 | Crescendo Biologics | Seed Round | 0 |
| 1/2010 | Crescendo Biologics | Series A | 0 |
| 4/2005 | CellCentric | Venture Round | 0 |
| 1/2005 | Takeda Cambridge | Venture Round | 0 |
| 1/2006 | NXVISION | Venture Round | 0 |
| 8/2005 | Intercytex Group | Series D | 0 |
| 11/2003 | Purely Proteins Limited | Series A | - |
| 7/2006 | CellCentric | Venture Round | 0 |
| 6/2004 | CellCentric | Series A | - |
| 12/2004 | Purely Proteins Limited | Series B | 0 |
| 7/2001 | De Novo Pharmaceuticals | Series B | 0 |
| 4/2000 | De Novo Pharmaceuticals | Series A | 3.2M |
| 7/2006 | Takeda Cambridge | Series D | 0 |
| 5/2005 | Amura | Venture Round | 0 |
| 1/2010 | Crescendo Biologics | Series A | 0 |
| 10/2009 | Crescendo Biologics | Seed Round | 0 |
| 7/2006 | CellCentric | Venture Round | 0 |
| 7/2006 | Takeda Cambridge | Series D | 0 |
| 1/2006 | NXVISION | Venture Round | 0 |
| 8/2005 | Intercytex Group | Series D | 0 |
| 5/2005 | Amura | Venture Round | 0 |
| 4/2005 | CellCentric | Venture Round | 0 |
| 1/2005 | Takeda Cambridge | Venture Round | 0 |
| 12/2004 | Purely Proteins Limited | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
